Your browser doesn't support javascript.
Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19.
Lim, Sarah; Tignanelli, Christopher J; Hoertel, Nicolas; Boulware, David R; Usher, Michael G.
  • Lim S; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Tignanelli CJ; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
  • Hoertel N; Université Paris Cité, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, INSERM U1266, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.
  • Boulware DR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Usher MG; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Open Forum Infect Dis ; 9(8): ofac389, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-2001404
ABSTRACT
This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid